AnaptysBio Stock Price. Everything You Need To Know About The AnaptysBio Stock!
AnaptysBio, Inc. is a clinical stage biotechnology company. The company is headquartered in San Diego, California and currently employs 96 full-time employees. The company went IPO on 2017-01-26. The company is focused on developing immune cell modulators, including two checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases. Its product candidate pipeline includes Rosnilimab, which is designed to suppress aberrant T cell driven inflammation by augmenting signaling through PD-1 or targeted depletion of PD-1+ T cells; ANB032, which is designed to augment BTLA signaling that is applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation; ANB033, which targets CD122, the common beta subunit shared by the IL-15 and IL-2 receptors; Imsidolimab, which inhibits the interleukin-36 receptor (IL-36R) and is developed for the treatment of generalized pustular psoriasis (GPP), and Etokimab, which inhibits IL-33 function and acts upstream of key cell types involved in atopy and the subsequent release of Th2 cytokines.
AnaptysBio Stock Price. Everything You Need To Know About The AnaptysBio Stock! performance
- Employees 96
- Company HQ San Diego
- Website https://www.anaptysbio.com/
- ANAB Asset Type Common Stock
- ANAB Market Capitalization 573.7M
- Earnings Per Share -6.08
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in international markets? Look no further than AnaptysBio, a promising stock that you should consider adding to your investment portfolio. AnaptysBio is a biotechnology company specializing in the discovery and development of novel antibodies. With their cutting-edge technology and focus on therapeutic advancements, AnaptysBio has garnered attention from investors worldwide. If you’re wondering how to invest in AnaptysBio from Malaysia, Thailand, Indonesia, or Vietnam, Zorion has got you covered. As an investment platform, Zorion provides a seamless and secure way for retail investors from these countries to invest in real US stocks, including AnaptysBio. We offer investment insights and recommendations to help you make informed decisions about your investments. But that’s not all – Zorion also goes the extra mile by providing comprehensive resources and educational materials. These resources will further enhance your investment knowledge, empowering you to navigate the stock market more effectively. So, whether you’re a seasoned investor or just starting out, seize this opportunity to invest in AnaptysBio and set yourself on the path to financial success. Trust Zorion to be your partner in your investment journey. Start investing now for a brighter tomorrow.
